COVID-19 has caused a surge in telemedicine, increasing access to health care without having to physically visit a doctor. In similar ways, it is changing things in the operating room, where advanced technology platforms enable surgeons and specialists to observe or weigh in on surgeries and allow manufacturer reps to assist in procedures using new devices.
While strong financial markets could create merger and acquisition headwinds for med tech, the volume of both M&As and deals are rising above each of the prior three years, indicating a growing industry interest that is not always clear in the financials.
HONG KONG – Coreline Soft Co. Ltd. has taken its first step into the Greater China market after receiving approval from Taiwan’s Food and Drug Administration (TFDA) on April 8 for its Aview suite of artificial intelligence (AI) medical solutions.
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: HHS, DOJ officials highlight pandemic response needs; FDA says plenty of respirators available; NICE supports use of Danis for variceal hemorrhage.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Activ Surgical.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biosig Technologies, Control Bionics, Genetic Technologies, Infinity Biologix, Lucira Health, Numotion, Outset Medical.
Keeping you up to date on recent developments in neurology, including: Blood test for depression, bipolar disorder developed; Specialized hydrogel helps repair circuitry in severe TBI; Using AI to diagnose neurological diseases based on motor impairment.
RSS
